Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Public Health Update topic

No spam. Unsubscribe anytime.

Black Hawk County health director reports medetomidine advisory, naloxone pilot and $1.02M HUD lead grant notice

Black Hawk County Board of Health · April 29, 2026
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Director Kaitlin Emrich told the Board of Health the department issued a health advisory about rising medetomidine in the illicit drug supply, piloted naloxone distribution at outreach events, and received notice of a $1.02 million HUD Lead Hazard Reduction Capacity Building Grant; an official award announcement is pending.

Kaitlin Emrich, director of Black Hawk County Public Health, told the board on April 29 that the department issued an April 2 health advisory warning of a rapid increase in medetomidine found as an adulterant in the U.S. illicit drug supply and urged continued harm-reduction outreach.

Emrich said the department has piloted naloxone distribution at outreach events and will roll out annual provider letters to clarify reporting requirements. She said Teletask mass-communication software was implemented to improve rapid messaging to partners and the public.

Emrich reported the department received notification from Senator Grassley’s office that a Lead Hazard Reduction Capacity Building Grant of $1.02 million from the U.S. Department of Housing and Urban Development (HUD) has been awarded to the department; she said an official announcement is pending. Emrich also warned the board of funding impacts tied to the termination of the Nucera Pharmacy and Iowa HHS contract, estimating reductions of $21,354 for FY26 and $50,708 for FY27 and noting Iowa HHS indicated it would handle emergency procurement if needed.

Board members asked staff to continue coordinating partner communications and to provide follow-up details on how the HUD grant will be used once the official award notice is received. The board took no formal vote on program changes during the update; items requiring action were scheduled for future meetings.

The board’s next regular meeting is set for May 27, 2026, at 7:30 a.m. in Room 220 at 1407 Independence Ave., Waterloo, where staff said they will provide additional implementation details for the grant and for naloxone distribution plans.